FTL anticorps (Middle Region)

N° du produit ABIN631142

L’anticorps Lapin Polyclonal anti-FTL a été validé pour WB. Il convient pour détecter FTL dans des échantillons de Humain et Rat.

Aperçu rapide pour FTL anticorps (Middle Region) (ABIN631142)

Antigène: FTL (Ferritin, Light Polypeptide (FTL))

Reactivité: Humain, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp FTL est non-conjugé

Application: Western Blotting (WB)

Détail du produit anti-FTL anticorps

Épitope: Middle Region

Specificité: FTL antibody was raised against the middle region of FTL

Purification: Affinity purified

Immunogène: FTL antibody was raised using the middle region of FTL corresponding to a region with amino acids ALLDLHALGSARTDPHLCDFLETHFLDEEVKLIKKMGDHLTNLHRLGGPE

Information d'application

Indications d'application: WB: 1 µg/mL
Optimal conditions should be determined by the investigator.

Commentaires:

FTL Blocking Peptide, , is also available for use as a blocking control in assays to test for specificity of this FTL antibody

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Reconstitution: Lyophilized powder. Add distilled water for a 1 mg/mL concentration of FTL antibody in PBS

Concentration: Lot specific

Buffer: PBS

Conseil sur la manipulation: Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use.

Stock: 4 °C/-20 °C

Stockage commentaire: Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.

Détails sur FTL

Antigène: FTL (Ferritin, Light Polypeptide (FTL))

Autre désignation: FTL

Sujet: FTL is the light subunit of the ferritin protein. Ferritin is the major intracellular iron storage protein in prokaryotes and eukaryotes. It is composed of 24 subunits of the heavy and light ferritin chains. Variation in ferritin subunit composition may affect the rates of iron uptake and release in different tissues. A major function of ferritin is the storage of iron in a soluble and nontoxic state. Defects in this light chain ferritin gene are associated with several neurodegenerative diseases and hyperferritinemia-cataract syndrome.

Poids moléculaire: 20 kDa (MW of target protein)

Pathways: Transition Metal Ion Homeostasis